Journal Home
Search for

Volume 21, Issue 7, Pages 502-507 (November 2009)


View previous. 8 of 20 View next.

Aprotinin use during cardiac surgery: recent alterations and effects on blood product utilization

Zaneta Y. Strouch, MD, MPH (Fellow)a, Melinda L. Drum, PhD (Assistant Professor, Research Associate)b, Mark A. Chaney, MD (Associate Professor, Director)aCorresponding Author Informationemail address

Received 20 May 2008; received in revised form 2 December 2008; accepted 4 December 2008. published online 28 October 2009.

Abstract 

Objective

To investigate a single institution's changing use of aprotinin and subsequent effects on intraoperative blood product utilization (red blood cells/fresh frozen plasma) and postoperative clinical bleeding requiring reoperation.

Design

Retrospective study.

Setting

Single university institution (University of Chicago).

Measurements

Data from 499 adult patients undergoing cardiac surgery requiring cardiopulmonary bypass (CPB) over a two-year period (February 2005 - January 2007) were reviewed. The first 12 months (Feb 2005 - Jan 2006, Group 2005-2006) of data were compared with that from the second 12-month period (Feb 2006 - Jan 2007, Group 2006-2007). Information regarding patient demographics, surgical procedures, aprotinin use (none, half-dose, full-dose), and blood product use during CPB was retrospectively retrieved and analyzed.

Main Results

When Group 2006-2007 data was compared with that from Group 2005-2006, full-dose aprotinin use had significantly decreased (58% to 17%, P < 0.001), non-use of aprotinin significantly increased (18% to 47%, P < 0.001), while fresh frozen plasma (FFP) utilization during CPB significantly increased (24% to 36%, P = 0.004). Red blood cell (RBC) transfusion rates remained stable (67% - 69%) yet rates of RBC and FFP transfusion during CPB significantly increased (23% to 34%, P = 0.003). There was also a trend toward increased unplanned reoperations for excessive clinical bleeding (0 pts in Group 2005-2006, three pts in Group 2006-2007).

Conclusions

As the institution's use of high-dose aprotinin has significantly decreased, the number of patients requiring FFP and FFP/RBC combinations during CPB has significantly increased. Furthermore, a trend toward increasing incidence of unplanned reoperations for excessive clinical bleeding was noted.

a Department of Anesthesia and Critical Care, University of Chicago Medical Center, Chicago, IL 60637, USA

b Department of Health Studies, University of Chicago Medical Center, Chicago, MC 4028, IL 60637, USA

Corresponding Author InformationCorresponding author. Tel.: +1 773 702 5951; fax: +1 773 834 3920.

PII: S0952-8180(09)00259-1

doi:10.1016/j.jclinane.2008.12.021


View previous. 8 of 20 View next.